Where does P-cure Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), P-cure Ltd. ranks #32,793 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does P-cure Ltd. hold?

P-cure Ltd. holds 8 US utility patents granted between 2016 and 2022, spanning 4 technology areas.

What is P-cure Ltd.'s Innovation Score?

P-cure Ltd. has an Innovation Score of 25.9 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does P-cure Ltd. focus on?

P-cure Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 7 patents, ranking #515 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is P-cure Ltd.'s patent grant rate increasing or decreasing?

P-cure Ltd.'s recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for P-cure Ltd.'s patents?

P-cure Ltd.'s patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the P-cure Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

P-cure Ltd.

USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, P-cure ranks #32,793 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.

#32,793
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.9/100): 15.9
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32793 · Foreign Corporation #32,793 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,793/49,997
PHOTO-FINISH Outsense Diagnostics
CPC-NARROW A61N · 4 areas
INNOV-THIN 25.9/100
CLAIMS-RICH 15.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Outsense Diagnostics Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How P-cure’s 25.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (29%) Velocity 1.7 pts (7%) Breadth 7.1 pts (27%) Claim depth 9.5 pts (37%)

Qualcomm Incorporated · highest

85
P-cure · this assignee

26
3D Lighting… · lowest

7

What this shows P-cure's Innovation Score is 25.9/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for P-cure?

Each dot is one of P-cure’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). P-cure’s own 15.9 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

P-cure vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where P-cure's grants concentrate

P-cure Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 87.5% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2018. By volume, P-cure sits between Outsense Diagnostics Ltd. and PAI Capital LLC.

P-cure's three-year grant acceleration

P-cure Ltd. shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Outsense Diagnost…

8
Overair

8
Oxford Instruments

8
Oztent Australia…

8
P T Archery

8
P V Nano Cell

8
Pacraft

8
PAI Capital

8
P-cure ◀

8

What this shows P-cure holds 8 patents at rank #32,778, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near P-cure

By rank, the assignees closest to #32,778 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in P-cure's primary technology class.

P-cure's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

P-cure Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	25.0%
2018	1	12.5%
2020	1	12.5%
2021	3	37.5%
2022	1	12.5%

Which technologies does P-cure Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 7

A61B - DIAGNOSIS; SURGERY; Identification 6

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 1

G06T - Image Data Processing OR Generation, IN General 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

P-cure Ltd.'s patent record in context - here's where to go next.

P-cure Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 87.5% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #32,793 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare P-cure Ltd. against Outsense Diagnostics Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.